Regeneron Pharmaceuticals is a biotechnology company based in Tarrytown, New York, that discovers and makes prescription medicines. Its products include treatments for serious eye diseases such as macular degeneration and diabetic eye conditions, an injectable medicine for eczema, asthma and other allergic conditions developed with a partner, and a cancer immunotherapy for certain skin and lung cancers. It also runs a large research effort in antibody technologies and genetics, serving patients through doctors and health systems in markets around the world.
The shares are listed on the London Exchange in UK under the code 0R2M, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1181 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
74/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average8.4%
From 52-week high-6.5%
MomentumStrong
78/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return22.4%
6-month return6.2%
12-month, skipping last month39.5%
Stability (higher is calmer)Fair
58/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)31.6%
Worst drawdown, 1 year (smaller is calmer)-26.0%
LiquidityWeak
47/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.56M USD
Zero-volume days0.0%
IncomeWeak
21/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.5%
Years with dividends2
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 563.61 – 870.00Daily closes, split-adjusted
Signals
50-day average792.16
200-day average734.46
Golden/death cross (60d)Golden, 33 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)32.92
Technical summary
Daily
Strongly bullish
12 bullish · 4 neutral · 0 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
770.4
Bullish
EMA 10
777.3
Bullish
SMA 20
764.6
Bullish
EMA 20
773.5
Bullish
SMA 50
792.2
Bullish
EMA 50
768.7
Bullish
SMA 100
725.5
Bullish
EMA 100
750.4
Bullish
SMA 200
734.5
Bullish
EMA 200
729.1
Bullish
Oscillators (daily)
RSI (14)
57.33
Neutral
MACD (12, 26)
1.57
Bullish
Momentum (12)
8.02
Bullish
Stochastic %K (14)
77.31
Neutral
Williams %R (14)
-22.69
Neutral
CCI (20)
74.89
Neutral
Pivot points (classic, last session)
S3
729.8
S2
747.4
S1
771.8
Pivot
789.4
R1
813.8
R2
831.4
R3
855.8
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
3.70 USD
Yield on today's price
0.46%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
18 Aug 2026
0.9400
20 May 2026
0.9400
20 Feb 2026
0.9400
20 Nov 2025
0.8800
18 Aug 2025
0.8800
20 May 2025
0.8800
20 Feb 2025
0.8800
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
